Buscar resultados de ensayos clínicos
Adrenogenital Syndrome - 82 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Examining Genetic Differences Among People With 21-Hydroxylase Deficiency Condición: 21-hydroxylase Deficiency Fecha: 2007-10-10 Intervenciones: Procedure: Hydrocortisone withdrawal This is considered a non-standard treatment. On Day 1, participants |
Completed |
Nombre del estudio: A Study Examining Doses of Abiraterone Acetate in Adult Women With 21-Hydroxylase Deficiency Condición: 21-hydroxylase Deficiency Fecha: 2011-11-23 Intervenciones: Drug: Abiraterone acetate Abiraterone acetate oral suspension administered daily from study Day 1 to stu |
Recruiting |
Nombre del estudio: Continuous Subcutaneous Hydrocortisone Infusion in Congenital Adrenal Hyperplasia Condición: Adrenal Hyperplasia, Congenital Fecha: 2013-01-10 Intervenciones:
|
Completed |
Nombre del estudio: Research Study for Children With Salt Wasting Congenital Adrenal Hyperplasia Condición: Adrenal Hyperplasia, Congenital Fecha: 2007-09-12 Intervenciones: Drug: Hydrocortisone sodium acetate Subcutaneous administration of medication via insulin pump |
Recruiting |
Nombre del estudio: A Study of ATR-101 for the Treatment of Congenital Adrenal Hyperplasia Condición: Congenital Adrenal Hyperplasia Fecha: 2016-06-01 Intervenciones: Drug: ATR-101 |
Completed |
Nombre del estudio: Cardiovascular Risk Profile in Patients With Congenital Adrenal Hyperplasia Condición: Congenital Adrenal Hyperplasia Fecha: 2012-11-16 |
Completed |
Nombre del estudio: Role of the Protein Osteoprotegerin in the Bone Health of Women With Congenital Adrenal Hyperplasia Condición: Adrenal Hyperplasia, Congenital Fecha: 2008-06-06 |
Completed |
Nombre del estudio: Study of UK Adults With Congenital Adrenal Hyperplasia. Condición: Congenital Adrenal Hyperplasia Fecha: 2008-09-08 |
Completed |
Nombre del estudio: Determining the Long-Term Effects of Prenatal Dexamethasone Treatment in Children With 21-Hydroxylase Deficiency and Their Mothers Condición: Adrenal Hyperplasia, Congenital Fecha: 2008-01-31 |
Withdrawn |
Nombre del estudio: Safety, Pharmacokinetics and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal Hyperplasia Condición: Congenital Adrenal Hyperplasia Fecha: 2015-01-20 Intervenciones: Drug: NBI-77860 |